Product Articles
The Obesity Drug Pipeline in 2026: GLP-1 and What Comes Next
A clear map of the GLP-1 and obesity drug market in 2026. What is approved, what is coming, the five bets each company is making, and how the economics changed.
A clear map of the GLP-1 and obesity drug market in 2026. What is approved, what is coming, the five bets each company is making, and how the economics changed.